Bayer's Babe seeks U.S. manufacturing policy

Greg Babe, president and CEO of Bayer, believes the U.S. should have a national manufacturing policy. He view promotes industry as the driver of legislation and regulation.

Babe tells IndustryWeek that the government should lower the corporate tax rate and promote financial reform to boost lending, invest in infrastructure, and promote science and engineering education. The U.S. needs a "holistic policy on manufacturing" to serve as a road map.

As a manufacturing exec in North America, Babe oversaw a 15 percent workforce cut at Bayer's MaterialScience business in 2007. He says the ideas of "simplify, standardize and automate" led to the group's transition, along with investments in automation for back-office functions.

- see the article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.